Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

444
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
444
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.8K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

13.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.0K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

348
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
348
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

702
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
702
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glycolysis and hexosamine biosynthesis regulate inflammatory protein expression and maturation and key steps of monocyte recruitment by human aortic valve cells.

American journal of physiology. Heart and circulatory physiology·2026
Same author

Commonalities in frailty and psychopathology predict chronotype across severe mental disorders from a comorbidity perspective.

Psychological medicine·2026
Same author

Glycemic Control and Adherence to Treatment According to Personality, Self-Esteem, and Perceived Stress in Type 1 Diabetes Mellitus.

Nursing research and practice·2026
Same author

Obesity as a Determinant of Periodontal Therapy Outcomes: Insights on Oxidative and Endoplasmic Reticulum Stress Pathways.

International dental journal·2026
Same author

Reliable discrimination of type 1 and type 2 diabetes by flow-through leukocyte-endothelium interactions exploiting advanced hydrodynamic detection parameters.

Analytical and bioanalytical chemistry·2026
Same author

Safety and Tolerability of the Gut Bacterium <i>Phascolarctobacterium faecium</i> DSM 32890.

Nutrients·2026

Related Experiment Video

Updated: Nov 18, 2025

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs
08:15

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs

Published on: August 15, 2025

714

Does Metformin Modulate Mitochondrial Dynamics and Function in Type 2 Diabetic Patients?

Aranzazu M de Marañón1, Francisco Canet1, Zaida Abad-Jiménez1

  • 1Service of Endocrinology and Nutrition, University Hospital Doctor Peset, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), Valencia, Spain.

Antioxidants & Redox Signaling
|February 9, 2021
PubMed
Summary
This summary is machine-generated.

Metformin improves mitochondrial function and dynamics in type 2 diabetes (T2D) patients. This diabetes drug also reduces harmful leukocyte-endothelial interactions, potentially combating early atherosclerosis.

Keywords:
inflammationmetforminmitochondrial dynamicsmitochondrial dysfunctiontype 2 diabetes

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.9K
High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
12:32

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

Published on: January 23, 2018

12.6K

Related Experiment Videos

Last Updated: Nov 18, 2025

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs
08:15

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs

Published on: August 15, 2025

714
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.9K
High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
12:32

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

Published on: January 23, 2018

12.6K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Metabolic Diseases

Background:

  • Type 2 Diabetes (T2D) is characterized by mitochondrial dysfunction.
  • Leukocytes from T2D patients exhibit increased reactive oxygen species (ROS), reduced mitochondrial membrane potential, and lower oxygen consumption.
  • Mitochondrial dynamics are altered in T2D, with decreased fusion proteins (MFN1, MFN2, OPA1) and increased fission proteins (FIS1, DRP-1).

Discussion:

  • Metformin treatment in T2D patients ameliorated mitochondrial dysfunction, restoring membrane potential and oxygen consumption.
  • Metformin normalized mitochondrial dynamics by upregulating fusion proteins and downregulating fission proteins.
  • The drug reduced enhanced leukocyte/endothelial interactions observed in T2D patients, a marker of early atherosclerosis.

Key Insights:

  • Metformin improves mitochondrial function and dynamics in type 2 diabetes.
  • Metformin treatment reverses key markers of mitochondrial dysfunction in T2D leukocytes.
  • Metformin mitigates pro-atherosclerotic leukocyte-endothelial interactions in T2D.

Outlook:

  • Investigate the precise mechanisms by which metformin improves mitochondrial function and dynamics in T2D.
  • Explore metformin's role in modulating leukocyte-endothelial interactions as a therapeutic strategy for early atherosclerosis.
  • Further research into metformin's impact on mitochondrial health could reveal new therapeutic targets for T2D and related vascular complications.